Clinical Trial: Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Migraine
Study Type: INTERVENTIONAL
Official Title: A Single Center, Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Fremanezumab (675 mg Quarterly) in Female Patients Aged 18-45 With Menstrual
Brief Summary:
The goal of this clinical trial is to learn about how a migraine prevention medicine works for people who have migraines/headaches with their menstrual period.The study includes people ages 18 to 45 who have been diagnosed with migraine and who have a migraine with their menstrual period or those who have migraines with their menstrual period and at other times of the month as well.The main question the study aims to answer are:• Does fremanazemab, an injectable calcitonin gene-related peptide (CGRP) pathway…
Read more